MedPath

Cardiotamine

Brand Name: Cardiotamine

Generic Name: Dobutamine (As Hydrochloride)

Active
Registration Number

DRP-5723-07

Dosage Form

Solution for Injection (IV Infusion)

Issuance Date

June 1, 2023

Expiry Date

July 18, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50mg/mL (250mg/5mL)
PackagingUSP Type I Glass Ampoule mL (box of 10's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Adrenergic Agent
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Dobutamine (As Hydrochloride)Active
Monograph: dobutamine (as hydrochloride)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform